Patents Assigned to Bonalive Biomaterials Oy
  • Publication number: 20200038547
    Abstract: The present invention relates to a bone implant comprising a porous body comprising particles of bioactive glass having a particle size of at least 500 ?m, wherein the composition of the bioactive glass is 45-59 weight-% of SiO2, 18-25 weight-% of Na2O, 17-25 weight-% of CaO and 0.1-6 weight-% of P2O5, and a film having a thickness of 10 ?m-200 ?m, made of a biocompatible polymer and arranged at least partially around the body.
    Type: Application
    Filed: October 4, 2017
    Publication date: February 6, 2020
    Applicant: BonAlive Biomaterials Oy
    Inventors: Fredrik OLLILA, Nina LINDFORS, Robert BJORKENHEIM, Gustav STROMBERG, Leena HUPA, Peter UPPSTU, Jukka PAJARINEN
  • Publication number: 20170072098
    Abstract: The present invention relates to an implantable paste comprising bioactive glass powder having a size distribution of 0.5-45 ?m, bioactive glass granules having a size distribution between 100 and 4000 ?m, low molecular weight polyethylene glycol having a molecular weight range of 200-700 g/mol, medium molecular weight polyethylene glycol having a molecular weight range of 700-2500 g/mol, high molecular weight polyethylene glycol having a molecular weight range of 2500-8000 g/mol and glycerol. The composition of the bioactive glass is 45-55 weight-% of SiO2, 20-25 weight-% of Na2O, 18-25 weight-% of CaO and 3-6 weight-% of P2O5, and the molecular weight of the low molecular weight polyethylene glycol and of the medium molecular weight polyethylene glycol differ from each other by at least 80 g/mol and that the molecular weight of the medium molecular weight polyethylene glycol and of the high molecular weight polyethylene glycol differ from each other by at least 300 g/mol.
    Type: Application
    Filed: March 16, 2015
    Publication date: March 16, 2017
    Applicant: BonAlive Biomaterials Oy
    Inventors: Lorenzo DRAGO, Carlo Luca ROMANO, Jimmy LUCCHESI, Fredrik OLLILA
  • Patent number: 8858976
    Abstract: The present invention relates to an implantable paste comprising bioactive glass spheres having a size distribution of 50-425 ?m, low molecular weight polyethylene glycol having a molecular weight range of 200-700 g/mol, medium molecular weight polyethylene glycol having a molecular weight range of 700-2500 g/mol and high molecular weight polyethylene glycol having a molecular weight range of 2500-8000 g/mol, with the proviso that the molecular weight of the low molecular weight polyethylene glycol and of the medium molecular weight polyethylene glycol differ from each other by at least 80 g/mol and that the molecular weight of the medium molecular weight polyethylene glycol and of the high molecular weight polyethylene glycol differ from each other by at least 300 g/mol.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: October 14, 2014
    Assignee: Bonalive Biomaterials Oy
    Inventors: Jukka Tuominen, Timo Lehtonen, Fredrik Ollila